Success Stories: Hematology and Oncology Fellow in Michigan Receives EB-2 NIW Approval

A Hematology and Oncology Fellow in Michigan Received EB-2 NIW (National Interest Waiver) Approval on December 24, 2013 (Approval Notice)

General Field: Oncology and Hematology

Position at the Time of Case Filing: Hematology and Oncology Fellow

Country of Origin: Jordan

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Michigan

Approval Notice Date: 12/24/2013

Processing Time: 3 Months, 21 Days Including RFE Response

Case Summary:

After 3 months, 21 days, North America Immigration Law Group – WeGreened.com received word that a Hematology and Oncology Fellow in Michigan received NIW approval. With a broad background in hematology and oncology studies, the client is well-informed on both the side effects of cancer treatments and the benefits of a new non-surgical method to remove tumors, known as cryotherapy. His work has resulted in 10 peer-reviewed journal publications, which had been cited 73 times at the time of the case filing. One of the six recommenders for this case assures that “[Client]’s investigations of side effects of different cancer treatments are integral to improving the quality of life, and even saving some of the lives of cancer patients. Indeed, while discovering viable treatments is certainly an essential piece in solving the cancer puzzle, understanding the side effects of such treatments are arguably as important, if not more so.” This case received NIW approval 3 months, 21 days after it was filed.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.